Pavelcova, K.; Bohata, J.; Pavlikova, M.; Bubenikova, E.; Pavelka, K.; Stiburkova, B.
Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout. J. Clin. Med. 2020, 9, 2510.
https://doi.org/10.3390/jcm9082510
AMA Style
Pavelcova K, Bohata J, Pavlikova M, Bubenikova E, Pavelka K, Stiburkova B.
Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout. Journal of Clinical Medicine. 2020; 9(8):2510.
https://doi.org/10.3390/jcm9082510
Chicago/Turabian Style
Pavelcova, Katerina, Jana Bohata, Marketa Pavlikova, Eliska Bubenikova, Karel Pavelka, and Blanka Stiburkova.
2020. "Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout" Journal of Clinical Medicine 9, no. 8: 2510.
https://doi.org/10.3390/jcm9082510
APA Style
Pavelcova, K., Bohata, J., Pavlikova, M., Bubenikova, E., Pavelka, K., & Stiburkova, B.
(2020). Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout. Journal of Clinical Medicine, 9(8), 2510.
https://doi.org/10.3390/jcm9082510